Reuters logo
BRIEF-Caladrius Biosciences Q1 loss per share $1.12
May 15, 2017 / 9:13 PM / 4 months ago

BRIEF-Caladrius Biosciences Q1 loss per share $1.12

May 15 (Reuters) - Caladrius Biosciences Inc

* Caladrius Biosciences announces 2017 first quarter financial results

* Q1 revenue rose 6 percent to $7.9 million

* Q1 loss per share $1.12

* Expects to provide more specifics on cash usage for balance of 2017 after closing of Hitachi transaction Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below